These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis]. Author: Ficheux M, Cuny P, Lecouf A, Ryckelynck JP, Hurault de Ligny B, Lobbedez T. Journal: Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234. Abstract: INTRODUCTION: The main objective of this study is to determine whether a single dose of iron dextran can correct iron deficiency during a period of four months in peritoneal dialysis patients. METHOD: This was a prospective observational study in peritoneal dialysis patients who had anemia (hemoglobin<11g/dL) and iron deficiency (ferritin<100μg/L and/or transferrin saturation<20%). Patients who were resistant to oral iron or who could not tolerate oral iron were included in the study. At baseline, based on the iron deficiency estimation, a single dose of iron dextran was infused over four hours. RESULTS: Of 17 patients included, 12 completed the study. The mean iron dose infused was 742±150mg. No clinically significant adverse event was reported during the infusion. Four months after the iron dextran infusion there was a significant increase of the mean hemoglobin level (10.1±0.7g/dl vs 11.4±1.2g/dL, P<0.05), the mean blood ferritin level (66±46mg/L vs 212±121mg/L, P<0.05) and the mean transferrin saturation (14±5% vs 23±8, P<0.05). Four months after the iron infusion 10 patients had a blood ferritin level higher than 100μg/L and a transferrin saturation higher than 20%. There was no significant modification of the erythropoietin dose during the four months period. CONCLUSION: In patients treated by peritoneal dialysis, the anemia due to iron deficiency can be treated by a single infusion of iron dextran for a period of four months.[Abstract] [Full Text] [Related] [New Search]